secwatch.observer — SEC 8-K summary
======================================

Issuer:     FITLIFE BRANDS, INC. (FTLF)
CIK:        0001374328
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001437749-25-016991
Event type: earnings
Sentiment:  negative
Materiality: 0.55
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FitLife Brands Q1 2025 revenue $15.9M (-4% YoY), net income $2.0M, diluted EPS $0.20
--------------------------------------------------------------------------------

- Total revenue $15.9M, down 4% YoY; net income $2.0M vs $2.2M; diluted EPS $0.20 vs $0.21.
- Adjusted EBITDA $3.4M, down 6% YoY; net debt $6.0M (0.4x trailing EBITDA).
- Legacy FitLife revenue up 5% YoY; MRC (Dr. Tobias) revenue down 11%; MusclePharm down 6%.
- MusclePharm launched Pro Series at Vitamin Shoppe in March; MRC skin care brands declined 14%.
- Company sees elevated M&A deal flow; balance sheet deleveraged with $6M cash and $12M term loans.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374328/000143774925016991/0001437749-25-016991-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374328/000143774925016991/ftlf20250514_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-016991

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer